Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma

Simona Primerano, Roberta Burnelli, Elisa Carraro, Marta Pillon, Caterina Elia, Piero Farruggia, Alessandra Sala, Luciana Vinti, Salvatore Buffardi, Giuseppe Basso, Maurizio Mascarin, Lara Mussolin

Research output: Contribution to journalArticle

Abstract

Levels of plasma cell-free DNA (cfDNA) of a large series of children with classical Hodgkin lymphoma (cHL) were evaluated and analyzed at diagnosis and during chemotherapy treatment in relation with clinical characteristics. CfDNA levels in cHL patients were significantly higher compared with controls (p=0.002). CfDNA at diagnosis was correlated with presence of B symptoms (p=0.027) and high erythrocyte sedimentation rate (p=0.049). We found that the increasing of plasma cfDNA after first chemotherapy cycle seems to be associated with a worse prognosis (p=0.049). Levels of plasma cfDNA might constitute an interesting non-invasive tool in cHL patients' management.

Original languageEnglish
Pages (from-to)364-6
Number of pages3
JournalJournal of Cancer
Volume7
Issue number4
DOIs
Publication statusPublished - 2016

Fingerprint

Plasma Cells
Hodgkin Disease
Pediatrics
DNA
Drug Therapy
Blood Sedimentation
Therapeutics

Keywords

  • Journal Article

Cite this

Primerano, S., Burnelli, R., Carraro, E., Pillon, M., Elia, C., Farruggia, P., ... Mussolin, L. (2016). Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma. Journal of Cancer, 7(4), 364-6. https://doi.org/10.7150/jca.13593

Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma. / Primerano, Simona; Burnelli, Roberta; Carraro, Elisa; Pillon, Marta; Elia, Caterina; Farruggia, Piero; Sala, Alessandra; Vinti, Luciana; Buffardi, Salvatore; Basso, Giuseppe; Mascarin, Maurizio; Mussolin, Lara.

In: Journal of Cancer, Vol. 7, No. 4, 2016, p. 364-6.

Research output: Contribution to journalArticle

Primerano, S, Burnelli, R, Carraro, E, Pillon, M, Elia, C, Farruggia, P, Sala, A, Vinti, L, Buffardi, S, Basso, G, Mascarin, M & Mussolin, L 2016, 'Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma', Journal of Cancer, vol. 7, no. 4, pp. 364-6. https://doi.org/10.7150/jca.13593
Primerano S, Burnelli R, Carraro E, Pillon M, Elia C, Farruggia P et al. Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma. Journal of Cancer. 2016;7(4):364-6. https://doi.org/10.7150/jca.13593
Primerano, Simona ; Burnelli, Roberta ; Carraro, Elisa ; Pillon, Marta ; Elia, Caterina ; Farruggia, Piero ; Sala, Alessandra ; Vinti, Luciana ; Buffardi, Salvatore ; Basso, Giuseppe ; Mascarin, Maurizio ; Mussolin, Lara. / Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma. In: Journal of Cancer. 2016 ; Vol. 7, No. 4. pp. 364-6.
@article{0e87c30e029149bca95191ae36799046,
title = "Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma",
abstract = "Levels of plasma cell-free DNA (cfDNA) of a large series of children with classical Hodgkin lymphoma (cHL) were evaluated and analyzed at diagnosis and during chemotherapy treatment in relation with clinical characteristics. CfDNA levels in cHL patients were significantly higher compared with controls (p=0.002). CfDNA at diagnosis was correlated with presence of B symptoms (p=0.027) and high erythrocyte sedimentation rate (p=0.049). We found that the increasing of plasma cfDNA after first chemotherapy cycle seems to be associated with a worse prognosis (p=0.049). Levels of plasma cfDNA might constitute an interesting non-invasive tool in cHL patients' management.",
keywords = "Journal Article",
author = "Simona Primerano and Roberta Burnelli and Elisa Carraro and Marta Pillon and Caterina Elia and Piero Farruggia and Alessandra Sala and Luciana Vinti and Salvatore Buffardi and Giuseppe Basso and Maurizio Mascarin and Lara Mussolin",
year = "2016",
doi = "10.7150/jca.13593",
language = "English",
volume = "7",
pages = "364--6",
journal = "Journal of Cancer",
issn = "1837-9664",
publisher = "Ivyspring International Publisher",
number = "4",

}

TY - JOUR

T1 - Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma

AU - Primerano, Simona

AU - Burnelli, Roberta

AU - Carraro, Elisa

AU - Pillon, Marta

AU - Elia, Caterina

AU - Farruggia, Piero

AU - Sala, Alessandra

AU - Vinti, Luciana

AU - Buffardi, Salvatore

AU - Basso, Giuseppe

AU - Mascarin, Maurizio

AU - Mussolin, Lara

PY - 2016

Y1 - 2016

N2 - Levels of plasma cell-free DNA (cfDNA) of a large series of children with classical Hodgkin lymphoma (cHL) were evaluated and analyzed at diagnosis and during chemotherapy treatment in relation with clinical characteristics. CfDNA levels in cHL patients were significantly higher compared with controls (p=0.002). CfDNA at diagnosis was correlated with presence of B symptoms (p=0.027) and high erythrocyte sedimentation rate (p=0.049). We found that the increasing of plasma cfDNA after first chemotherapy cycle seems to be associated with a worse prognosis (p=0.049). Levels of plasma cfDNA might constitute an interesting non-invasive tool in cHL patients' management.

AB - Levels of plasma cell-free DNA (cfDNA) of a large series of children with classical Hodgkin lymphoma (cHL) were evaluated and analyzed at diagnosis and during chemotherapy treatment in relation with clinical characteristics. CfDNA levels in cHL patients were significantly higher compared with controls (p=0.002). CfDNA at diagnosis was correlated with presence of B symptoms (p=0.027) and high erythrocyte sedimentation rate (p=0.049). We found that the increasing of plasma cfDNA after first chemotherapy cycle seems to be associated with a worse prognosis (p=0.049). Levels of plasma cfDNA might constitute an interesting non-invasive tool in cHL patients' management.

KW - Journal Article

U2 - 10.7150/jca.13593

DO - 10.7150/jca.13593

M3 - Article

C2 - 26918050

VL - 7

SP - 364

EP - 366

JO - Journal of Cancer

JF - Journal of Cancer

SN - 1837-9664

IS - 4

ER -